Therillia appoints chief business officer
Montreal-based drug developer Therillia Development Company Inc has hired Dr. Pierre Beauparlant as chief business officer. Previously, he worked at Novartis Pharmaceuticals Canada where he was medical therapeutic head of hematology. Therillia is backed by Sanderling Ventures, an investment firm focused on new biomedical companies.
5 December 2016•3 mins read
